![W. Hertz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
W. Hertz
Algemeen Directeur bij
GRI BIO, INC.
Vermogen: 14 $ op 30-06-2026
Profiel
Dr. W.
M.
Hertz is a President, Chief Executive Officer & Director at GRI Bio, Inc., a President, Chief Executive Officer & Director at GRI Bio Operations, Inc. and a Chairman at Multimeric Biotherapeutics, Inc. He is on the Board of Directors at GRI Bio, Inc. and GRI Bio Operations, Inc. Dr. Hertz was previously employed as a Chief Executive Officer & Director by Vallon Pharmaceuticals, Inc., a Chairman by Evozym Biologics, Inc., and a Chief Executive Officer by Pharmexa, Inc. (New York).
He also served on the board at Gemvax AS.
He received his undergraduate degree from Bowdoin College and a doctorate degree from CU Anschutz Medical Campus.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-01-2026 | 8 ( 0% ) | 14 $ | 30-06-2026 |
Actieve functies van W. Hertz
| Bedrijven | Functie | Begin |
|---|---|---|
| GRI BIO, INC. | Algemeen Directeur | 01-04-2023 |
Multimeric Biotherapeutics, Inc.
 Multimeric Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a early-stage biotech company | Oprichter | 01-01-1998 |
GRI Bio Operations, Inc.
 GRI Bio Operations, Inc. BiotechnologyHealth Technology Operates as a bio-technology company which develops cell based therapies for inflammatory diseases | Oprichter | 01-01-2009 |
Eerdere bekende functies van W. Hertz
| Bedrijven | Functie | Einde |
|---|---|---|
Evozym Biologics, Inc.
 Evozym Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technology platform that utilizes evolutionary biology to transform gene profiles into novel proteins | Voorzitter | 01-01-2018 |
Gemvax AS
 Gemvax AS Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Directeur/Bestuurslid | 01-01-2009 |
Pharmexa, Inc. (New York) | Algemeen Directeur | 01-08-2008 |
| GRI BIOPAR | Algemeen Directeur | - |
Opleiding van W. Hertz
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
3
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Evozym Biologics, Inc.
Evozym Biologics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops technology platform that utilizes evolutionary biology to transform gene profiles into novel proteins | Commercial Services |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemvax AS
Gemvax AS Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Pharmexa, Inc. (New York) | |
Multimeric Biotherapeutics, Inc.
Multimeric Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a early-stage biotech company | Health Technology |
GRI Bio Operations, Inc.
GRI Bio Operations, Inc. BiotechnologyHealth Technology Operates as a bio-technology company which develops cell based therapies for inflammatory diseases | Health Technology |
CU Anschutz Medical Campus
 CU Anschutz Medical Campus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes proprietary biopharmaceutical products | Health Technology |
GRI Bio, Inc.
 GRI Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of inflammatory, fibrotic and autoimmune diseases | Health Technology |
Kies MarketScreener 
